Treatment Considerations for Patients With a History of Head and Neck Radiation Therapy

By Bridget M. Wright, MACPR, BSDH, EFDA and Matthew J. Messina, DDS

Patients with head and neck cancer (HNC) comprise approximately 4% of all patients with cancer.1 In the United States, an estimated 66,920 people will be diagnosed with HNC and about 15,400 of those will die in 2023.2 Generally, the survival rate for HNC is increasing, although the exact rate is challenging to determine because of the variability between types.3–5

* References can be found in the original article via the link below.
Read Article

CONTRIBUTE: Are you interested in contributing to the student website? Click here to submit an article idea!

Related Articles


This site uses Akismet to reduce spam. Learn how your comment data is processed.